Page last updated: 2024-10-31

nefazodone and Obesity

nefazodone has been researched along with Obesity in 1 studies

nefazodone: may be useful as an opiate adjunct

Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dunner, DL1
Laird, LK1
Zajecka, J1
Bailey, L1
Sussman, N1
Seabolt, JL1

Reviews

1 review available for nefazodone and Obesity

ArticleYear
Six-year perspectives on the safety and tolerability of nefazodone.
    The Journal of clinical psychiatry, 2002, Volume: 63 Suppl 1

    Topics: Age Factors; Antidepressive Agents, Second-Generation; Body Weight; Chronic Disease; Depressive Diso

2002